These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34016944)

  • 21. STYK1 promotes cancer cell proliferation and malignant transformation by activating PI3K-AKT pathway in gallbladder carcinoma.
    Hu YP; Wu ZB; Jiang L; Jin YP; Li HF; Zhang YJ; Ma Q; Ye YY; Wang Z; Liu YC; Chen HZ; Liu YB
    Int J Biochem Cell Biol; 2018 Apr; 97():16-27. PubMed ID: 29413947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of eukaryotic translation initiation factor 4E associates with a poor prognosis in gallbladder cancer and promotes cell proliferation in vitro and in vivo.
    Fang D; Peng J; Wang G; Zhou D; Geng X
    Int J Mol Med; 2019 Oct; 44(4):1325-1332. PubMed ID: 31432159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MYBL2 is a Potential Prognostic Marker that Promotes Cell Proliferation in Gallbladder Cancer.
    Liang HB; Cao Y; Ma Q; Shu YJ; Wang Z; Zhang F; Ye YY; Li HF; Xiang SS; Song XL; Xu Y; Zhang YC; Bao RF; Yuan RY; Zhang YJ; Hu YP; Jiang L; Li ML; Wang XA; Wu XS; Wu WG; Zhao S; Fand Y; Cui XP; Lu YS; Zhou J; Zheng L; Gong W; Liu YB
    Cell Physiol Biochem; 2017; 41(5):2117-2131. PubMed ID: 28427077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BRD9 promotes the progression of gallbladder cancer via CST1 upregulation and interaction with FOXP1 through the PI3K/AKT pathway and represents a therapeutic target.
    Qiang J; Zhao C; Shi LQ; Sun SR; Wang HK; Liu SL; Yang ZY; Dong P; Xiang SS; Wang JD; Shu YJ
    Gene Ther; 2024 Sep; ():. PubMed ID: 39306629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tamoxifen inhibits cell proliferation by impaired glucose metabolism in gallbladder cancer.
    Huang S; Wang H; Chen W; Zhan M; Xu S; Huang X; Lin R; Shen H; Wang J
    J Cell Mol Med; 2020 Jan; 24(2):1599-1613. PubMed ID: 31782270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD44 is overexpressed and correlated with tumor progression in gallbladder cancer.
    He Y; Xue C; Yu Y; Chen J; Chen X; Ren F; Ren Z; Cui G; Sun R
    Cancer Manag Res; 2018; 10():3857-3865. PubMed ID: 30288117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA MALAT1 potentiates growth and inhibits senescence by antagonizing ABI3BP in gallbladder cancer cells.
    Lin N; Yao Z; Xu M; Chen J; Lu Y; Yuan L; Zhou S; Zou X; Xu R
    J Exp Clin Cancer Res; 2019 Jun; 38(1):244. PubMed ID: 31174563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-143-5p Deficiency Triggers EMT and Metastasis by Targeting HIF-1α in Gallbladder Cancer.
    He M; Zhan M; Chen W; Xu S; Long M; Shen H; Shi Y; Liu Q; Mohan M; Wang J
    Cell Physiol Biochem; 2017; 42(5):2078-2092. PubMed ID: 28803245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of Pin1 as a Key Molecule for EMT Induction by Activation of STAT3 and NF-κB in Human Gallbladder Cancer.
    Nakada S; Kuboki S; Nojima H; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Miyazaki M; Ohtsuka M
    Ann Surg Oncol; 2019 Mar; 26(3):907-917. PubMed ID: 30610554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The PLGF/c-MYC/miR-19a axis promotes metastasis and stemness in gallbladder cancer.
    Li H; Jin Y; Hu Y; Jiang L; Liu F; Zhang Y; Hao Y; Chen S; Wu X; Liu Y
    Cancer Sci; 2018 May; 109(5):1532-1544. PubMed ID: 29575299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and functional characterization of INPP4B in gallbladder cancer patients and gallbladder cancer cells.
    Wu Y; Meng D; Xu X; Bao J; You Y; Sun Y; Li Y; Sun D
    BMC Cancer; 2021 Apr; 21(1):433. PubMed ID: 33879096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ARRB1 Drives Gallbladder Cancer Progression by Facilitating TAK1/MAPK Signaling Activation.
    Zhang X; Kong Z; Xu X; Yun X; Chao J; Ding D; Li T; Gao Y; Guan N; Zhu C; Qin X
    J Cancer; 2021; 12(7):1926-1935. PubMed ID: 33753990
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Qin J; Wang W; An F; Huang W; Ding J
    J Cancer; 2019; 10(20):4939-4946. PubMed ID: 31598166
    [No Abstract]   [Full Text] [Related]  

  • 34. Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2.
    Wang SH; Wu XC; Zhang MD; Weng MZ; Zhou D; Quan ZW
    Tumour Biol; 2016 Jul; 37(7):9721-30. PubMed ID: 26803515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma.
    Chen J; Yu Y; Chen X; He Y; Hu Q; Li H; Han Q; Ren F; Li J; Li C; Bao J; Ren Z; Duan Z; Cui G; Sun R
    Cell Prolif; 2018 Dec; 51(6):e12510. PubMed ID: 30105813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulated NOX1 expression in gallbladder cancer‑associated fibroblasts predicts a poor prognosis.
    Wang FT; Hassan M; Ansari KH; Xu GL; Li XP; Fan YZ
    Oncol Rep; 2019 Oct; 42(4):1475-1486. PubMed ID: 31364740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased expression of hsa‑miR‑372 predicts poor prognosis in patients with gallbladder cancer by affecting chloride intracellular channel 1.
    Zhou N; Cheng W; Peng C; Liu Y; Jiang B
    Mol Med Rep; 2017 Nov; 16(5):7848-7854. PubMed ID: 28944858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of
    Tian C; Zhang B; Ge C
    Oncol Lett; 2020 Sep; 20(3):2677-2688. PubMed ID: 32782584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FOXK1 Promotes Proliferation and Metastasis of Gallbladder Cancer by Activating AKT/mTOR Signaling Pathway.
    Wencong M; Jinghan W; Yong Y; Jianyang A; Bin L; Qingbao C; Chen L; Xiaoqing J
    Front Oncol; 2020; 10():545. PubMed ID: 32363163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lower miR-630 expression predicts poor prognosis of osteosarcoma and promotes cell proliferation, migration and invasion by targeting PSMC2.
    Li GW; Yan X
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1915-1925. PubMed ID: 30915734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.